Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism.

[1]  G. Bell,et al.  Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. , 1993, Molecular pharmacology.

[2]  C. Saper,et al.  Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylylcyclase. , 1992, The Journal of biological chemistry.

[3]  R. Spielman,et al.  Familial and sporadic hyperinsulinism: histopathologic findings and segregation analysis support a single autosomal recessive disorder. , 1991, The Journal of pediatrics.

[4]  C. Stanley,et al.  Management of hyperinsulinism in infants. , 1991, The Journal of pediatrics.

[5]  A. Harris,et al.  Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide. Results of the International Multicenter Acromegaly Study Group. , 1991, Archives of internal medicine.

[6]  D. Wynick,et al.  Clinical review 23: The use of the long-acting somatostatin analog octreotide in the treatment of gut neuroendocrine tumors. , 1991, The Journal of clinical endocrinology and metabolism.

[7]  J. Hawdon,et al.  Tolerance to somatostatin analogue in a preterm infant with islet cell dysregulation syndrome. , 1991, Archives of disease in childhood.

[8]  R. Bergman,et al.  Treatment with a somatostatin analog decreases pancreatic B-cell and whole body sensitivity to glucose. , 1990, The Journal of clinical endocrinology and metabolism.

[9]  G. Bruining.  Recent advances in hyperinsulinism and the pathogenesis of diabetes mellitus , 1990 .

[10]  T. Declue,et al.  Linear growth during long-term treatment with somatostatin analog (SMS 201-995) for persistent hyperinsulinemic hypoglycemia of infancy. , 1990, The Journal of pediatrics.

[11]  G. Mcclure.  Surfactant Replacement Therapy , 1990 .

[12]  R. Broadbent,et al.  Somatostatin analogue SMS 201‐995 in the short‐term management of neonatal hyperinsulinism due to nesidioblastosis , 1988, Australian paediatric journal.

[13]  J. Jackson,et al.  Long-acting somatostatin analog in refractory neonatal hypoglycemia: follow-up information. , 1988, Jornal de Pediatria.

[14]  P. Hindmarsh,et al.  Somatostatin analogue in short term management of hyperinsulinism. , 1988, Archives of disease in childhood.

[15]  R. Odink,et al.  101 GROWTH IN A GIRL WITH NESIDIOBLASTOSIS DURING AND AFTER TEATMENT WITH THE SOMATOSTATIN ANALOGUE: SMS 201–995 , 1988, Pediatric Research.

[16]  D. Wilson,et al.  Long‐term Use of Somatostatin Analogue SMS 201–995 in the Treatment of Hypoglycaemia Due to Nesidioblastosis , 1988, Acta paediatrica Scandinavica.

[17]  P. Hindmarsh,et al.  Short-term management of nesidioblastosis using the somatostatin analogue SMS 201-995. , 1987, The New England journal of medicine.

[18]  D. Ha,et al.  Long-term treatment of an infant with nesidioblastosis using a somatostatin analogue. , 1987 .

[19]  S. Lamberts,et al.  Normalization of glucose homeostasis by a long-acting somatostatin analog SMS 201-995 in a newborn with nesidioblastosis. , 1986, Acta endocrinologica. Supplementum.

[20]  D. Cook,et al.  EFFECTS OF SOMATOSTATIN ANALOGUE SMS 201–995 IN NORMAL MAN , 1986, Clinical endocrinology.

[21]  P. Bougnères,et al.  Treatment of insulin excess by continuous subcutaneous infusion of somatostatin and glucagon in an infant. , 1985, The Journal of pediatrics.

[22]  P. Marbach,et al.  SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. , 1982, Life sciences.

[23]  T. Adrian,et al.  EFFECT OF SOMATOSTATIN INFUSION ON INTERMEDIARY METABOLISM AND ENTERO‐INSULAR HORMONE RELEASE IN INFANTS WITH HYPERINSULINAEMIC HYPOGLYCAEMIA , 1981, Acta paediatrica Scandinavica.

[24]  R. Filler,et al.  Hypoglycemia of infancy and nesidioblastosis. Studies with somatostatin. , 1977, The New England journal of medicine.

[25]  B. Glaser,et al.  Long-term treatment with the somatostatin analogue SMS 201-995: alternative to pancreatectomy in persistent hyperinsulinaemic hypoglycaemia of infancy. , 1990, Digestion.

[26]  M. Silink,et al.  Somatostatin treatment of insulin excess due to β-cell adenoma in a neonate** , 1980 .

[27]  C. Stanley,et al.  Hyperinsulinism in infants and children: diagnosis and therapy. , 1976, Advances in pediatrics.